Is a
Clinical Study attributes
NCT Number
Health Conditions in Trial
Trial Recruitment Size
4600
Trial Sponsor
Clinical Trial Start Date
2013
0Primary Completion Date
2014
0Study Completion Date
2014
0Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Treatment0
Intervention Type
Other0
Drug0
Intervention Name
ITCA 6500
ITCA placebo0
Interventional Trial Phase
Phase 30
Participating Facility
Official Name
Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of ITCA 650 in Patients With Type 2 Diabetes0
Last Updated
August 18, 2015
0Allocation Type
Randomized0
Intervention Model
Parallel Assignment0
Masking Type
Quadruple0
Masked Party
Investigator0
Outcomes Assessor0
Care Provider0
Participant0
Study summary
Phase 3 study to examine whether treatment with ITCA-650 60 mcg/day or 40 mcg/day is superior to placebo when added to current therapy in reducing HbA1c in patients with type 2 diabetes.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
